Bisoprolol Fumarate Tablets 5mg – For Laboratory Research Use Only

描述

Bisoprolol fumarate is a cardioselective ?1-adrenergic receptor blocker widely studied in research models involving hypertension, heart failure, and arrhythmia mechanisms. Its action helps reduce heart rate and cardiac output, making it useful in cardiovascular pharmacology research.

This product, branded as Bosoping, is formulated as 5mg bisoprolol fumarate per tablet and comes in a packaging of 20 tablets (10 tablets × 2 blister packs). It is manufactured by Huayi Pharmaceutical Technology (Anhui) Co., Ltd., approved by the China NMPA under registration number H20243009, with product code 86983781000028.

For research use only. Not intended for human or veterinary use.

Product Specifications

Mechanism of Action & Research Applications

Bisoprolol selectively blocks ?1-adrenergic receptors in the heart, reducing the effects of adrenaline and noradrenaline. This leads to decreased heart rate, cardiac output, and blood pressure, making it useful in:

• Cardiovascular pharmacodynamics

• Hypertension and heart failure model studies

• Beta-blocker comparative efficacy research

• Adrenergic receptor signaling studies

• Long-term metabolic effect simulations

Observed Side Effects in Laboratory Models

In preclinical or research contexts, observed side effects may include:

• Bradycardia

• Hypotension

• Fatigue or lethargy in animal models

• Altered blood glucose levels

Handling & Safety Information

Use Restriction: For laboratory research only
Protective Equipment: Use gloves, goggles, and lab coat during handling
Storage: Keep sealed below 25°C, in a dry place away from direct light
Disposal: Follow institutional chemical disposal protocols

Research Use Disclaimer

This product is supplied exclusively for scientific laboratory research. It is not intended for human or animal consumption, clinical use, or diagnostic applications. Any misuse may result in safety or legal consequences. Always adhere to your institution’s chemical safety guidelines.